Study: Treatable Cause of High Blood Pressure Often Ignored

People whose blood pressure is hard to control might have another condition that’s the real culprit. So why aren’t they being tested for primary aldosteronism?

5:00 AM

Author | Haley Otman

Stethscope and pills
Getty Images

A new study highlights a chicken-or-the-egg scenario in blood pressure management: Testing for a disease that's associated with difficult-to-control blood pressure isn't happening, possibly because providers think it's rare or unwieldy, but if more people were tested, experts say we'd discover it's not rare at all.

The findings are frustrating but not surprising, says co-senior author J. Brian Byrd, M.D., M.S., an assistant professor and cardiologist at the Michigan Medicine Frankel Cardiovascular Center. Byrd, an expert on hypertension, worked with several colleagues at the University of Pennsylvania and Stanford University.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily updates on iTunes, Google Play and Stitcher

"We're all taught in medical school that if a patient has high blood pressure and low levels of potassium in the blood, or if a patient isn't seeing improvement after blood pressure treatment, you should check for primary aldosteronism," Byrd says. "It's universally taught that this is a definitive cause of high blood pressure in some people, so we wanted to see how commonly this testing is done."

Byrd and colleagues reviewed data from military veterans diagnosed with treatment-resistant hypertension at a Veterans Health Administration facility between 2000 and 2017. They found that fewer than 2% of the people who should've been evaluated for primary aldosteronism were tested. The chances of receiving a needed evaluation were higher when the patient also saw a specialist such as a nephrologist or an endocrinologist to discuss their hypertension.

The most recent blood pressure guideline, from the American Heart Association and American College of Cardiology, recommends testing for the condition in the same situations Byrd said are taught in medical schools.

"There's an educational gap there where some physicians may think it's too complicated to test people for this, or don't know they should be thinking about testing people," Byrd explains. "The most important take-home message for clinicians is: if you're really struggling to control a patient's blood pressure, consider getting a hypertension expert involved who has special training."

SEE ALSO: Specialist: New Hypertension Guidelines Will Facilitate Earlier Intervention

In his clinic, Byrd has seen many patients who hadn't yet been diagnosed with primary aldosteronism, which means blood pressure continued to be uncontrolled, putting them at risk of strokes or heart attacks.

"The frustrating part is that there are effective treatments for primary aldosteronism," Byrd says. "But if no one diagnoses it, it can't be treated, and it's also harder to study primary aldosteronism when it's so rarely diagnosed."

Byrd says current estimates suggest that around 20% of people with uncontrolled hypertension despite taking three blood pressure medications may actually be struggling with this treatable disorder.

If you're really struggling to control a patient's blood pressure, consider getting a hypertension expert involved who has special training.
James Brian Byrd, M.D.

Management of primary aldosteronism depends on the type diagnosed, and may include medications to block the effect of aldosterone in the adrenal gland, or surgery to remove one of the two adrenal glands.

In addition to encouraging conversations with specialists when dealing with uncontrolled blood pressure, the researchers suggest exploring technology to help solve this problem. That could include an automatic alert prompted in patients' electronic health record when they meet conditions to warrant an evaluation for primary aldosteronism, Byrd says.

Paper cited: "Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans." Annals of Internal Medicine. DOI: 10.7326/M20-4873


More Articles About: Body Work Hypertension and High Blood Pressure Cardiovascular: Preventive Cardiology Lab Tests Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories stethoscope blue yellow
Health Lab
Researchers uncover novel mechanism that leads to high blood pressure
Researchers at Michigan Medicine have uncovered a key mechanism that regulates blood pressure and vascular remodeling in people with a genetic variant linked to high blood pressure.
doctors in surgery room over surgery table with cooler open with labels on it
Health Lab
Why donor hearts fail in cold storage — and how to prevent it
Researchers have discovered a new molecular process that occurs when donor hearts are preserved in cold storage which contributes to failure after transplant, a study in both humans and animals shows. Fortunately, therapy that is typically prescribed for high blood pressure can target this process to reduce cold preservation associated with cardiac injury. This discovery has potential to improve the consistent function of donor hearts and extend the distance they can be safely transported in cold storage.
up close doctor in hospital with cardiology close up scans on monitors
Health Lab
Researchers find significant differences in care of life threatening shock after heart attack
A study finds most hospitals don’t see many cardiogenic shock patients. When they do, providers often do not have a standardized way of treating them.
blood vessel up close with red cells and yellow inside
Health Lab
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammals 
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.
woman touching head talking to front desk person
Health Lab
Cognitive decline comes sooner for people with heart failure
There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study led by University of Michigan suggests. 
hands on book reading
Health Lab
Highly educated people face steeper mental declines after stroke
Stroke survivors who have attended some level of higher education may face even steeper mental declines, according to a study led by Michigan Medicine.